Global Point-of-Care Glucose Testing Market by Product (Glucometers, Test Strips, Lancets, Control Solutions), by Application (Diabetes Monitoring, Critical Care, Emergency Care), by End-Use Industry (Hospitals, Diagnostic Laboratories, Home Care, Ambulatory Care Centers); Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Point-of-Care Glucose Testing Market was valued at USD 3.0 Billion in 2024-e and will surpass USD 6.1 Billion by 2030; growing at a CAGR of 12.8% during 2025 - 2030.

The Point-of-Care (POC) Glucose Testing market is experiencing rapid growth, driven by the increasing prevalence of diabetes and the rising demand for immediate, on-site testing solutions. POC glucose testing enables healthcare providers and individuals to monitor blood glucose levels in real time, facilitating prompt treatment decisions and better management of diabetes. As diabetes continues to be one of the most common chronic conditions globally, the demand for quick, accurate, and reliable glucose testing devices has surged. This market encompasses products such as glucometers, test strips, lancets, and control solutions, each playing a crucial role in ensuring effective glucose monitoring across various healthcare settings.

The convenience and accuracy offered by point-of-care glucose testing solutions are transforming patient care, allowing for timely interventions in critical situations. These devices are particularly essential for managing diabetes, as well as in emergency care scenarios, where immediate blood glucose levels are necessary to assess patient conditions. Additionally, advancements in glucose testing technologies, such as non-invasive methods and portable devices, are further driving market growth and expanding the reach of these solutions in both clinical and home care environments.

Glucometers Segment Is Largest Owing To High Adoption for Diabetes Monitoring

Glucometers are the largest product segment in the Point-of-Care Glucose Testing market, owing to their widespread adoption for diabetes monitoring. These devices are essential for individuals with diabetes, enabling them to track their blood glucose levels at home, in ambulatory care settings, and in hospitals. Glucometers provide real-time readings, which are crucial for managing blood glucose levels, adjusting medication, and preventing complications associated with diabetes. Their ease of use, portability, and affordability have contributed to their dominance in the market.

The demand for glucometers is driven by the growing incidence of diabetes worldwide and the need for continuous monitoring to manage the condition effectively. In addition, the increasing awareness of the importance of self-monitoring among diabetic patients has further fueled the demand for glucometers. The availability of advanced features, such as Bluetooth connectivity and integration with mobile apps, has also enhanced the functionality of glucometers, making them even more appealing to consumers and healthcare providers alike. As diabetes management continues to be a priority, glucometers are expected to remain the largest product segment in the market.

Diabetes Monitoring Application Is Largest Owing To High Prevalence of Diabetes

The diabetes monitoring application is the largest segment in the Point-of-Care Glucose Testing market, driven by the high prevalence of diabetes globally. Diabetes is one of the most common chronic diseases, and effective blood glucose monitoring is critical to managing the condition. Point-of-care glucose testing offers an accessible and convenient solution for individuals with diabetes to monitor their glucose levels on a daily basis. Regular monitoring helps in making timely adjustments to medication, diet, and lifestyle, preventing complications such as hypoglycemia, hyperglycemia, and long-term organ damage.

The increasing number of diabetic patients, along with growing awareness about the importance of monitoring glucose levels, has propelled the demand for point-of-care glucose testing devices. Healthcare providers, particularly in hospitals, ambulatory care centers, and home care settings, rely on these devices to assess patient conditions, provide immediate care, and manage treatment plans effectively. As the global diabetes burden continues to rise, the diabetes monitoring application will remain the largest and most significant segment in the market.

Hospitals End-Use Industry Is Largest Owing To High Demand for Critical Care and Diabetes Management

The hospitals end-use industry represents the largest segment in the Point-of-Care Glucose Testing market. Hospitals play a central role in the diagnosis, treatment, and management of diabetes and other conditions that require immediate glucose monitoring, such as critical care and emergency care. Glucose testing is a routine procedure in hospitals, where rapid and accurate measurements are essential for making treatment decisions, especially in critical or emergency situations. The need for frequent monitoring of blood glucose levels in patients with diabetes, as well as in those experiencing acute medical conditions, drives the demand for point-of-care glucose testing systems in hospitals.

Hospitals also benefit from the integration of point-of-care glucose testing devices into their existing healthcare infrastructure, enabling real-time results and facilitating faster decision-making. Additionally, with the increasing prevalence of hospital-acquired conditions related to diabetes, the role of glucose testing in managing patient outcomes has become even more vital. The high volume of patients requiring glucose monitoring in hospital settings will continue to support the growth of the hospital segment in the point-of-care glucose testing market.

North America Region Is Largest Owing To Advanced Healthcare Systems and High Diabetes Prevalence

North America is the largest region in the Point-of-Care Glucose Testing market, driven by advanced healthcare infrastructure, high diabetes prevalence, and the adoption of cutting-edge medical technologies. The United States, in particular, has a large population of individuals diagnosed with diabetes, creating a significant demand for point-of-care glucose testing devices. The region's well-established healthcare systems and widespread access to advanced medical technologies also support the growth of this market. Additionally, the high awareness of diabetes management and the importance of glucose monitoring contribute to the region’s dominance.

The strong presence of key players in the market, along with the availability of insurance coverage for diabetes management tools, further drives the adoption of point-of-care glucose testing solutions in North America. As the region continues to face rising healthcare costs and an aging population, the demand for efficient and cost-effective diabetes management tools, such as glucometers and test strips, is expected to remain strong. North America is anticipated to continue leading the market due to its healthcare infrastructure, strong regulatory environment, and commitment to addressing the growing diabetes epidemic.

Competitive Landscape and Key Players

The Point-of-Care Glucose Testing market is highly competitive, with numerous players working to develop and provide innovative glucose testing solutions. Leading companies in this space include Abbott Laboratories, Roche Diagnostics, Medtronic, and Ascensia Diabetes Care. Abbott Laboratories, known for its FreeStyle family of glucometers, has been a prominent player in the market, offering a range of glucose monitoring systems that are widely used in both clinical and home care settings. Roche Diagnostics also offers a broad portfolio of glucose monitoring products, including the Accu-Chek series, which is widely recognized for its reliability and accuracy.

Competition in the market is driven by continuous technological advancements, such as the development of non-invasive glucose testing methods, wireless connectivity, and integration with digital health platforms. Companies are focusing on improving the user experience, offering features like Bluetooth-enabled devices, mobile app integration, and real-time data sharing to enhance patient care. As the demand for effective diabetes management solutions continues to rise, leading companies will focus on expanding their product offerings and improving the accuracy, affordability, and convenience of their devices.

Recent Developments:

• Abbott Laboratories launched a new version of its FreeStyle Libre glucose monitoring system that enhances accuracy and provides continuous glucose monitoring for diabetes management.
• Medtronic received FDA approval for its next-generation point-of-care glucose testing system, designed to streamline diabetes care in emergency and critical care settings.
• Roche Diagnostics introduced an innovative Point-of-Care glucose testing device with integrated software for real-time analytics, aiding in the immediate management of patients' glucose levels.
• Dexcom, Inc. announced an expansion of its Point-of-Care glucose monitoring system into home healthcare markets, providing patients more accessibility to real-time glucose data.
• Siemens Healthineers introduced a portable blood glucose meter that delivers lab-quality results in emergency medical settings, improving patient care in urgent scenarios.

List of Leading Companies:

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Medtronic
• Johnson & Johnson
• Bayer AG
• Ascensia Diabetes Care
• Arkray, Inc.
• Dexcom, Inc.
• Lifescan, Inc.
• Trividia Health
• ACON Laboratories, Inc.
• Nipro Corporation
• B. Braun Melsungen AG
• Philips Healthcare

Report Scope: